The need for integrated clinical and administrative data models for risk adjustment in assessment of the cost transplant care.

Incorporating accurate clinical data into risk-adjustment methodologies can improve risk adjustment methodologies; however, as majority of variation in cost remains unexplained by these risk-adjustment models further work is needed to accuracy assess transplant value.